ARTICLE
ejd.2012.1700
Auteur(s) : Xu-Feng Du1 docdxf@126.com, Xing-Ping Yin2, Guo-Long Zhang1, He-Jian Shi1, Min-Hua Shao1
1 Department of Dermatology,
Wuxi People's Hospital,
299 Qingyang Road,
214023Wuxi, China
2 Department of Dermatology,
Wuxi No.2 People's Hospital,
Wuxi, China
Interstitial granulomatous drug reaction (IGDR) is a recently
proposed drug-associated entity [1]. Many cases of IGDR have been
reported in the literature, mostly induced by Western medicines,
such as diuretics, antihistamines, sennoside, etc [1-4]. Lee et
al reported a case of IGDR triggered by an unknown constituent
of Chinese herbal medicine, in 2005 [5]. Panax notoginseng
saponins (PNS) are the principal elements extracted from the
traditional Chinese herb medicine Sanchi and have been widely used
for cardiovascular and cerebrovascular diseases [6]. Here we
described a case of IGDR to PNS.
A 73-year-old male presented to our department with
asymptomatic, erythematous to carmine or violaceous macules,
papules and plaques on his trunk and extremities for one month
(figures
1A-B). Prior to developing the lesions, he had taken
PNS soft capsules and aspirin pills for cerebral infarction, for
about 2 months. Physical examination showed many slightly
infiltrated and scaly macules, papules and plaques on the trunk and
extremities, round to ovoid in shape. All the lesions gradually
regressed two months later, after he stopped the PNS capsules. He
had no arthritis, photosensitivity or any signs of collagen
diseases. Complete blood cell count and urine analysis were within
normal ranges and antinuclear antibody, rheumatoid factor,
anti-ds-DNA, anti-Smith antibody were negative. No abnormality was
noticed on the chest X-ray and the PPD test was negative. Two skin
biopsies, taken respectively from fresh and old lesions, showed
similar findings. A dense, diffuse, interstitial/perivascular,
infiltrative mass, composed of lymphocytes, histiocytes, plasma
cells and eosinophils, was found in the dermis, accompanied with
sparse mucin deposition, atypical lymphocytes and erythrocyte
extravasion in some areas. Leukocytoclasis and fibrinoid necrosis
of the walls of small cutaneous blood vessels were not found.
Granuloma, composed of epithelioid cells, mononuclear histiocytes,
multinucleate giant cells and other inflammatory cells, was found
and rosette-like collections of epithelioid cells surrounding thick
collagen fibers were seen (figures
1C-E). Liquifaction degeneration of basal cells was
observed in the fresh lesion. Four months later, the patient
visited our department with almost identical eruptions again, after
5 days of only intravenous PNS injections. The eruptions gradually
resolved 2 months after cessation of the medicine. IGDR was
diagnosed according to the medical history and clinicopathological
features and there was no recurrence in the 1-year follow-up.
IGDR was first described in 1998 [1]. Its mechanism is
uncertain, it is assumed that inherent immune dysregulation may
promote an exaggerated immune response to drugs in some cases [4].
Different clinical presentations, such as annular plaques,
generalized erythematous macular and/or papular lesions, erythema
nodosum-like lesions and different body sites, such as the back,
trunk, extremities and palmoplantar areas, have been reported to
date. Histopathologically, IGDR has various features [1-5], such as
a diffuse interstitial/perivascular infiltration of lymphocytes and
histiocytes in the dermis, sometimes associated with interstitial
mucin deposition and interface dermatitis. Atypical lymphocytes may
also be seen in some cases.
In the present case, the patient had identical lesions after
using either PNS capsules orally or its injection intravenously and
the eruptions gradually resolved after cessation of the drug.
Absence of leukocytoclasis and fibrinoid necrosis of the walls of
blood vessels excluded the diagnosis of drug-induced vasculitis.
The medical history, clinical manifestations and pathological
findings strongly suggested the diagnosis of IGDR to PNS.
PNS include more than 30 kinds of saponins. In our patient,
the pathogenesis of IGDR to PNS is unclear, and we assume that an
inherent immune dysregulation may have promoted an exaggerated and
delayed immune reaction to any type(s) of PNS constituents.
Disclosure
Financial support : none. Conflict of
interest : none
References
1. Magro CM, Crowson AN, Schapiro BL. The interstitial
granulomatous drug reaction: a distinctive clinical and
pathological entity. J Cutan Pathol 1998; 25: 72-9.
2. Chen YC, Hsiao CH, Tsai TF. Interstitial granulomatous
drug reaction presenting as erythroderma: remission after
discontinuation of enalapril maleate. Br J Dermatol 2008;
158: 1143-5.
3. Marcollo Pini A, Kerl K, Kamarachev J, French LE,
Hofbauer GF. Interstitial granulomatous drug reaction following
intravenous ganciclovir. Br J Dermatol 2008; 158:
1391-3.
4. Regula CG, Hennessy J, Clarke LE, et al.
Interstitial granulomatous drug reaction to anakinra. J Am Acad
Dermatol 2008; 59: S25-7.
5. Lee HW, Yun WJ, Lee MW, Choi JH, Moon KC, Koh JK.
Interstitial granulomatous drug reaction caused by a Chinese herbal
medication. J Am Acad Dermatol 2005; 52: 712-3.
6. Jia Y, Li ZY, Zhang HG, Li HB, Liu Y, Li XH. Panax
notoginseng saponins decrease cholesterol ester via up-regulating
ATP-binding cassette transporter A1 in foam cells. J
Ethnopharmacol 2010; 28: 297-302.
|